Target intelligence / Profile preview

Sirtuin family protein (SIRT)

Target
SIRT
Molecular classification
Enzyme, Histone deacetylase, Transcriptional regulator, Signaling protein
01

Overview

Sirtuin family proteins are a highly conserved group of enzymes that function primarily as NAD+-dependent lysine deacylases and/or mono ADP-ribosyltransferases. They regulate a wide range of biological processes including epigenetic gene silencing through histone modification; DNA repair; cellular metabolism; oxidative stress response; apoptosis; cell cycle progression; and organismal aging/longevity. The founding member was discovered in yeast (Sir2), with mammalian homologs named SIRTs followed by numbers indicating specific isoforms (e.g., SIRT1–7). Each member has distinct subcellular localization—nuclear (e.g., SIRT1, SIRT6, SIRT7), cytoplasmic (e.g., SIRT2), mitochondrial (e.g., SIRTs3–5)—and unique substrate specificity/functionality. Their dysregulation is implicated in diverse diseases including cancer progression/metastasis, neurodegeneration, cardiovascular dysfunction, metabolic syndrome, and age-related pathologies.

Other names
Sir2 proteinSilent information regulator 2NAD-dependent deacetylaseMono-ADP-ribosyltransferaseSirtuins
02

Mechanism of action

Drugs targeting sirtuins generally act by modulating their enzymatic activity. Mechanisms include: - Activation of NAD+-dependent deacetylation or ADP-ribosylation activity to promote beneficial effects on metabolism and aging. - Inhibition of sirtuin activity to alter cell survival pathways in cancer or other diseases.

03

Biological functions

Regulation of metabolismDNA repairEpigenetic gene silencing/modificationCell cycle regulationApoptosis controlOxidative stress responseAging and longevity regulation
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseMetabolic disorders
05

Safety considerations

Notable safety concerns include the potential for off-target effects due to the broad role of sirtuins in essential cellular processes such as DNA repair and metabolism. Modulation can impact cell survival pathways—raising concerns about tumor promotion/suppression balance and metabolic disturbances.
06

Interacting drugs

Piceatannol

21 more in the full profile.

07

Biomarkers

There are no universally established clinical biomarkers for all sirtuins. However: Expression levels of specific sirtuin isoforms such as SIRT1 or SIRT7 may serve as biomarkers in cancer prognosis or aging studies.

Beyond the preview

Go deeper on Sirtuin family protein (SIRT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sirtuin family protein (SIRT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call